AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Renalytix AI (NASDAQ:RNLX)
-- USD
0.000 0.000%Sponsored Reports
Loading...
| Previous Close (in USD) | 0.142 |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 4.038/0.245 |
| EBITDA (in USD) | -37.79M |
| PE Ratio | -- |
| Volume | -- |
| Diluted Eps TTM | -0.77 |
| Total Assets (in USD) | 42.117M |
|---|---|
| Total Liabilities (in USD) | 23.663M |
| Revenue TTM (in USD) | 2.41M |
| Cash (in USD) | 24.682M |
| Market Cap (in USD) | 36.250 M |
| Revenue Per Share TTM | 0.052 |
| Gross Profit TTM (in USD) | 0.72M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Renalytix AI
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. James R. McCullough M.B.A. | CEO & Exec. Director | 1968 |
| 2. | Mr. Fergus Fleming | CTO & Exec. Director | 1967 |
| 3. | Mr. Thomas H. McLain CPA, M.B.A | Pres | 1959 |
| 4. | Mr. Oliver James Sterling III | Chief Financial Officer | NA |
| 5. | Ms. Andria Parks-Herrera | VP of Marketing | NA |
| 6. | Ms. Jean M. Casner | Sr. VP & Chief HR Officer | 1959 |
| 7. | Mr. Baljit Singh | Head of Clinical Operations | NA |
| 8. | Dr. Michael J. Donovan M.D., Ph.D. | Chief Medical Officer | 1954 |
| 9. | Mr. Salim Hamir F.C.A. | Company Sec. | NA |
| 10. | Mr. James R. McCullough M.B.A. | Chief Executive Officer | 1968 |
Peers
Sector: Healthcare
Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
VEEV
Veeva Systems Inc Class A |
-2.010 1.244% | 162.5 | 54.610 | 33.223 | 12.830 | 6.727 | 11.138 | 58.844 |
|
MTHRF
M3 Inc |
0.000 0.000% | 11 | 29.720 | 25.000 | 0.046 | 4.379 | 0.041 | 0.118 |
|
MTHRY
M3 Inc |
-0.040 0.797% | 4.99 | 31.840 | 26.247 | 0.047 | 4.597 | 0.041 | 0.118 |
|
BTSG
BrightSpring Health Services, Inc. Common Stock |
+0.150 0.238% | 63.565 | 100.220 | 40.650 | 0.690 | 4.925 | 0.918 | 25.797 |
Income Statement
(Currency in USD)| Breakdown | 30-06-2023 | 30-06-2022 | 30-06-2021 | 30-06-2020 | 30-06-2019 |
|---|---|---|---|---|---|
| Income Before Tax | -46.221M | -49.628M | -35.788M | -10.61M | -6.518M |
| Minority Interest | - | 0M | 0.611M | - | - |
| Net Income | -46.223M | -56.732M | -31.01M | -9.25M | -5.559M |
| Selling General Administrative | 43.056M | 12.951M | 8.374M | 11.078M | 6.537M |
| Gross Profit | 0.701M | 0.918M | 0.687M | - | - |
| Reconciled Depreciation | 2.492M | 0.489M | 0.282M | 1.248M | 1.125M |
| Ebit | -37.989M | -57.372M | -32.611M | -10.593M | -6.537M |
| Ebitda | -35.497M | -45.111M | -39.411M | -11.078M | -5.373M |
| Depreciation And Amortization | 2.492M | 12.261M | -6.8M | -0.485M | 1.164M |
| Operating Income | -42.355M | -57.372M | -32.611M | -11.078M | -6.537M |
| Other Operating Expenses | 45.758M | 60.342M | 34.102M | 11.078M | 6.537M |
| Interest Expense | - | 0.002M | 0.003M | 0.002M | 0.02M |
| Tax Provision | 0.002M | 0.025M | -4.778M | -1.36M | -0.959M |
| Interest Income | 0.509M | 9.637M | 0.236M | 0.194M | 0.034M |
| Net Interest Income | 0.509M | 9.637M | -2.977M | 0.531M | 0.019M |
| Income Tax Expense | 0.002M | 7.104M | -4.778M | -1.36M | -0.959M |
| Total Revenue | 3.403M | 2.97M | 1.491M | 0M | 0M |
| Total Operating Expenses | 43.056M | 58.29M | 33.298M | 11.078M | 6.537M |
| Cost Of Revenue | 2.702M | 2.052M | 0.804M | - | - |
| Total Other Income Expense Net | -3.384M | 7.744M | -3.177M | 0.468M | 0.019M |
| Net Income From Continuing Ops | -46.223M | -45.276M | -35.336M | -9.25M | -5.559M |
| Net Income Applicable To Common Shares | -45.607M | -45.276M | -34.725M | -9.25M | -4.934M |
Balance Sheet
(Currency in USD)| Breakdown | 30-06-2023 | 30-06-2022 | 30-06-2021 | 30-06-2020 | 30-06-2019 |
|---|---|---|---|---|---|
| Total Assets | 42.117M | 63.258M | 102.578M | 41.298M | 28.922M |
| Intangible Assets | - | 14.02M | 18.021M | 17.118M | 18.287M |
| Other Current Assets | 0.566M | 2.194M | -0.001M | 4.277M | 0.11M |
| Total Liab | 23.663M | 20.089M | 7.476M | 5.336M | 0.755M |
| Total Stockholder Equity | 18.454M | 43.169M | 95.102M | 35.962M | 28.167M |
| Other Current Liab | 0.01M | 4.876M | 5.237M | 0.271M | 0.44M |
| Common Stock | 0.299M | 0.241M | 0.233M | 0.192M | 0.175M |
| Capital Stock | 0.299M | 0.228M | 0.233M | 0.192M | 0.175M |
| Retained Earnings | -99.184M | -52.961M | 3.771M | 34.852M | -5.977M |
| Good Will | - | - | - | - | - |
| Other Assets | 1.101M | 1.189M | 7.172M | 2.402M | 0.959M |
| Cash | 24.682M | 41.333M | 65.159M | 13.293M | 9.288M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 16.133M | 12.205M | 7.263M | 3.383M | 0.755M |
| Current Deferred Revenue | -0.01M | 0.046M | 0.122M | - | - |
| Net Debt | -12.532M | -28.626M | -64.807M | -12.671M | -9.288M |
| Short Term Debt | 4.619M | 4.823M | 0.139M | 0.213M | - |
| Short Long Term Debt | 4.463M | 4.66M | 0.053M | 0.121M | 0M |
| Short Long Term Debt Total | 12.15M | 12.707M | 0.352M | 0.622M | - |
| Other Stockholder Equity | 118.789M | 95.889M | 91.098M | 2.833M | 34.564M |
| Property Plant Equipment | 1.186M | 2.558M | 2.49M | 0.945M | 0.278M |
| Total Current Assets | 28.334M | 47.431M | 76.007M | 18.896M | 9.398M |
| Long Term Investments | - | - | - | 1.937M | - |
| Short Term Investments | 1.46M | 2.744M | 9.295M | 0.982M | - |
| Net Receivables | 0.776M | 0.901M | 1.201M | 0.018M | 0.015M |
| Long Term Debt | 7.485M | 7.682M | - | 0.134M | - |
| Inventory | 0.718M | 1.16M | 0.353M | 0.326M | - |
| Accounts Payable | 11.514M | 2.46M | 1.765M | 2.899M | 0.755M |
| Accumulated Other Comprehensive Income | -1.45M | - | - | -1.915M | -0.595M |
| Non Currrent Assets Other | 0.051M | 1.451M | -1.081M | 0.083M | - |
| Non Current Assets Total | 13.783M | 15.827M | 26.571M | 22.402M | 19.524M |
| Capital Lease Obligations | 0.202M | 0.365M | 0.299M | 0.367M | - |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 30-06-2023 | 30-06-2022 | 30-06-2021 | 30-06-2020 | 30-06-2019 |
|---|---|---|---|---|---|
| Investments | 0M | -0.662M | 1M | -0.849M | -13.049M |
| Total Cashflows From Investing Activities | - | -0.662M | -0.751M | -0.849M | -9.787M |
| Total Cash From Financing Activities | 15.118M | 25.515M | 77.239M | 16.542M | 26.249M |
| Net Income | -46.221M | -49.628M | -35.788M | -10.61M | -6.518M |
| Change In Cash | -16.651M | -23.826M | 51.866M | 5.996M | 9.206M |
| Begin Period Cash Flow | 41.333M | 65.159M | 13.293M | 7.297M | 0.082M |
| End Period Cash Flow | 24.682M | 41.333M | 65.159M | 13.293M | 9.288M |
| Total Cash From Operating Activities | -32.674M | -45.745M | -24.632M | -10.061M | -3.994M |
| Depreciation | 2.492M | 2.613M | 2.096M | -0.485M | 1.125M |
| Other Cashflows From Investing Activities | - | - | -0.229M | -0.061M | -0.061M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | 0.442M | -0.807M | -0.027M | -0.326M | -0.326M |
| Sale Purchase Of Stock | - | - | - | - | - |
| Other Cashflows From Financing Activities | -0.16M | 16.302M | 0.202M | 0.172M | -13.049M |
| Capital Expenditures | 0M | 0.694M | 1.63M | 1.312M | 13.049M |
| Change In Working Capital | 6.184M | 0.016M | 3.615M | -0.662M | 0.867M |
| Other Non Cash Items | -0.055M | -5.756M | -0.495M | 0.063M | -0.959M |
| Free Cash Flow | -32.674M | -46.439M | -26.262M | -11.373M | -17.043M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Victory Small Cap Stock | 2 years ago | 25288 |
| 2. | Granahan Inv Mgt Sm-Cap Core Gr | 2 years ago | 25288 |
| 3. | Pinnacle Turnaround Fund Composite | 2 years ago | 20000 |
| 4. | Allspring Essential Small Cap Value Equi | 2 years ago | 15678 |
| 5. | Balaguer 98 de Inversiones SICAV | 3 years ago | 14411 |
| 6. | Inver-99 SICAV | 3 years ago | 14296 |
| 7. | Pinnacle International ADR | 2 years ago | 9825 |
| 8. | Fidelity Nasdaq Composite Index | 2 years ago | 4865 |
| 9. | Lazard Digital Health A Acc USD | 2 years ago | 1918 |
| 10. | Granahan Small Cap Select | 2 years ago | 456 |
| 11. | Lazard Digital Health ADR | 2 years ago | 70 |
| 12. | Pinnacle International Small Cap Equity | 2 years ago | 300000 |
| 13. | Lazard Digital Health | 2 years ago | 119025 |
| 14. | Pinnacle Turnaround Fund Composite | 2 years ago | 20000 |
| 15. | Fidelity Nasdaq Composite Index | 2 years ago | 4865 |
| 16. | Lazard Digital Health A Acc USD | 2 years ago | 1943 |
| 17. | Lazard Digital Health ADR | 2 years ago | 70 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | CVI Holdings LLC | 2 years ago | 1144305 |
| 2. | Pinnacle Associates Inc | 2 years ago | 846534 |
| 3. | Gilder Gagnon Howe & CO LLC | 2 years ago | 761108 |
| 4. | Pentwater Capital Management LP | 2 years ago | 630000 |
| 5. | Stifel Financial Corp | 2 years ago | 558400 |
| 6. | Tejara Capital Ltd | 2 years ago | 500394 |
| 7. | CI Private Wealth LLC | 2 years ago | 335514 |
| 8. | Lazard Asset Management LLC | 2 years ago | 136620 |
| 9. | Nantahala Capital Management, LLC | 2 years ago | 117644 |
| 10. | JPMorgan Chase & Co | 2 years ago | 48329 |
| 11. | North Star Investment Management Corp | 2 years ago | 43000 |
| 12. | Morgan Stanley - Brokerage Accounts | 2 years ago | 29664 |
| 13. | EWA, LLC | 2 years ago | 28374 |
| 14. | XTX Topco Ltd | 2 years ago | 22047 |
| 15. | Wealth Enhancement Advisory Services, LLC | 2 years ago | 19613 |
| 16. | LPL Financial Corp | 2 years ago | 18518 |
| 17. | Virtu Financial LLC | 2 years ago | 14293 |
| 18. | Millennium Management LLC | 2 years ago | 13883 |
| 19. | Ironwood Investment Counsel, LLC | 2 years ago | 12000 |
| 20. | WHITE BAY PT LLC | 2 years ago | 1809 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...